Then, the question for the BTA management is: is BTA receiving the loyalties from the sales of Relenza that is manufactured by Simcere in China?
To be a good drug deveolper is not enough to bring wealth to shareholders. BTA must also learn to be good market player.
- Forums
- ASX - By Stock
- iv relenza trial in us
Then, the question for the BTA management is: is BTA receiving...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)